AQUESTIVE THERAPEUTICS INC. - COMMON STOCK

Aquestive Therapeutics to Announce Fourth Quarter and Year End 2020 Financial Results and Recent Business Highlights on March 9 and Host Conference Call on March 10 at 8:00 a.m. ET

17 2 2021 06:30:00 提供 Nasdaq GlobeNewswire

Aquestive Therapeutics Strengthens Board of Directors with Appointments of Julie Krop, M.D., and Marco Taglietti, M.D., and Announces Resignation of Douglas K. Bratton from Board of Directors

09 2 2021 06:30:00 提供 Nasdaq GlobeNewswire

Aquestive Therapeutics Appoints Mark Lepore, MD, as Chief Medical Officer for Allergy

28 1 2021 06:30:00 提供 Nasdaq GlobeNewswire

Aquestive Therapeutics Provides Business Update

07 1 2021 06:30:00 提供 Nasdaq GlobeNewswire

Aquestive Therapeutics to Present at Two Upcoming Investor Conferences

04 1 2021 06:30:00 提供 Nasdaq GlobeNewswire